Apton Biosystems Overview

  • Founded
  • 2012

Founded
  • Status
  • Private

  • Employees
  • 35

Employees
  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $24.7M

  • Investors
  • 7

Apton Biosystems General Information

Description

Developer of super-resolution multiomic systems for research and clinical applications. The company re-imagined the optical systems for sequencing and protein detection using super-resolution to evaluate molecules spaced closer than the wavelength of light.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 6670 Owens Drive
  • Pleasanton, CA 94588
  • United States
+1 (650) 000-0000

Apton Biosystems Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Apton Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 29-Apr-2021 $24.7M 000.00 000.00 Completed Generating Revenue
2. Seed Round 31-Aug-2019 000.00 000.00 000.00 Completed Product Development
1. Seed Round 18-Mar-2015 $7.29M $7.29M 000.00 Completed Startup
To view Apton Biosystems’s complete valuation and funding history, request access »

Apton Biosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.00
Seed-1 7,447,037 $0.000000 $3 $3 1x $3 12.03%
Seed 3,647,549 $0.000000 $2 $2 1x $2 5.89%
To view Apton Biosystems’s complete cap table history, request access »

Apton Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of super-resolution multiomic systems for research and clinical applications. The company re-imagined the opti
Diagnostic Equipment
Pleasanton, CA
35 As of 2022
000.00
00.00 0000-00-00
00000000000 000.00

000000

t. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pari
0000000000000
San Diego, CA
000 As of 0000
00000
0.000 0000-00-00
00000000000 00000

000000

tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proide
0000000000000
San Diego, CA
000 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Apton Biosystems Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Element Biosciences Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
0000000 Formerly VC-backed San Diego, CA 000 00000 000000&0 00000
000000 00000000000 Accelerator/Incubator Backed Munich, Germany 000 000000000000
00000 00000000000 Formerly VC-backed Marlborough, MA 000 00000 00000000 00000
00000000 00000000 Formerly VC-backed La Jolla, CA 000 00000 00000000 00000
To view Apton Biosystems’s complete competitors history, request access »

Apton Biosystems Patents

Apton Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210334957-A1 Densley-packed analyte layers and detection methods Pending 19-Sep-2018 0000000000
EP-3853382-A4 Densely-packed analyte layers and detection methods Pending 19-Sep-2018 0000000000 0
EP-3853382-A1 Densely-packed analyte layers and detection methods Pending 19-Sep-2018 0000000000
JP-2022501026-A Highly packed layers of analytes and detection methods Pending 19-Sep-2018 0000000000
US-20210381036-A1 Methods and composition for high throughput single molecule protein detection systems Pending 25-Jan-2018 C12Q1/6834
To view Apton Biosystems’s complete patent history, request access »

Apton Biosystems Executive Team (6)

Name Title Board Seat Contact Info
John Hanna Chief Executive Officer & Board Member
Bryan Staker Founder, Chief Technology Officer & Board Member
Scott Gorton Chief Financial Officer
You’re viewing 3 of 6 executive team members. Get the full list »

Apton Biosystems Board Members (9)

Name Representing Role Since
Bryan Staker Apton Biosystems Founder, Chief Technology Officer & Board Member 000 0000
Geoffrey Smith Ph.D Self Board Member 000 0000
Heiner Dreismann Ph.D Self Chairman 000 0000
Jay Kern Kern Capital Board Member 000 0000
John Hanna Apton Biosystems Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Apton Biosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Apton Biosystems Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Casdin Capital Hedge Fund Minority 000 0000 000000 0
Kern Capital Venture Capital Minority 000 0000 000000 0
Tri-Valley Ventures Venture Capital Minority 000 0000 000000 0
Cenova Capital Venture Capital Minority 000 0000 000000 0
Co-Win Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »